Summary: Pharmacy Times interviews Bia Labate, Ph.D., of MAPS and Chacruna Institute and psychiatric pharmacist Kelan Thomas, Pharm.D., M.S., about the significant scale of current clinical trials involving …
Originally appearing here. In this all new episode of the MAPS Podcast, Zach Leary sits down with NYU’s Dr. Tony Bossis to talk about a single dose of psilocybin can provide an entirely new perspective …
Summary: Listen to MAPS Founder and Executive Director Rick Doblin, Ph.D., on The Recount’s Hell & High Water podcast, where he and John Heilemann discuss exciting developments in the field …
Originally appearing here. This all new episode of the MAPS Podcast features an interview with Dr. Robin Carhart-Harris, a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, …
Summary: “In the MAPS approach,” Science Magazine explains, “therapists are advised not to steer the conversation toward trauma, but to create a safe space to ‘support the participant’s …
Summary; “In the 30 years since the pharmaceutical revolution began, psychiatry may be the only medical field to lose ground to its diseases,” says Scott Shannon, M.D. “Until MDMA, perhaps.” …
The findings were powerful enough that Mitchell believes they not only could mean that MDMA will become a frontline treatment for PTSD, but that similar drugs could emerge with their own therapeutic value. …
We’ve finally reached the point where we can shout our good news from the roof tops and publicly celebrate the work of this amazing team! The publication of our MAPP1 findings is official as of this …
Summary: At this year’s American Psychiatric Association (APA) Annual Meeting, Michael Mithoefer, M.D., of MAPS Public Benefit Corporation (MAPS PBC) celebrates the success of MAPS’ first Phase …
Summary: “At MAPS and the Zendo Project, we feel that it is important that, as we explore the potential benefits of psychedelics, we also make room to address the risks associated with psychedelic …
Psychedelic Science 2021 Webinar Series presented by the Multidisciplinary Association for Psychedelic Studies (MAPS) In this multidisciplinary online course, we’ll explore the latest advancements …
In February, New Jersey reduced criminal penalties for possession of up to an ounce of psilocybin, as well as legalized cannabis. The MAPS Policy and Advocacy team has been working closely with California …
